The Vallejo artist who redefined independence just made the biggest power move of the year. Is this the new blueprint for hip-hop success?
Rockstar has locked the date for our return to Vice City. Get ready for a marketing blitz that’s about to swallow the internet whole.
The Vallejo artist who redefined independence just made the biggest power move of the year. Is this the new blueprint for hip-hop success?
Rockstar has locked the date for our return to Vice City. Get ready for a marketing blitz that’s about to swallow the internet whole.
In a significant win for Black-led innovation in biotech/health-tech, Alveus Therapeutics (highlighted in recent "Black Innovation" roundups) has exited stealth mode with a massive $160 million in funding.The company is developing alternatives to popular weight-loss drugs like Ozempic, positioning itself as a major player in the life sciences sector for 2026. The Scoop: In a massive win for biotech, Alveus Therapeutics launched with $160 million in Series A funding on January 8. They are developing next-gen oral drugs for obesity and metabolic disease that could rival Ozempic. Impact on Black Culture & Community: This is a dual-impact story. Economically, it showcases Black leadership in the high-stakes world of biotech venture capital. Culturally, it addresses a health equity crisis ; metabolic diseases disproportionately affect Black communities due to systemic food apartheid. A Black-led company solving this issue implies a solution that might prioritize accessibility and trust in medical systems where it has historically been lacking.
By Jan 2026, Black unemployment hit 7.5% (vs. ~4% national average), a stark increase signaling a specific "Black Recession."